Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
SMC backs five new medicines for NHS use
The Scottish Medicines Consortium (SMC) has accepted five new medicines for use by NHS Scotland in its June 2021 decisions.
New research identifies single biomarker that can indicate underlying neurodegeneration
New research has identified a single biomarker that can be used to accurately identify underlying neurodegeneration among people with cognitive issues.
US report found it plausible COVID-19 leaked from Wuhan lab
WASHINGTON—A report on the origins of COVID-19 by a U.
Many Existing Drugs Could Be Potent COVID Fighters: Study
MONDAY, June 7, 2021 (HealthDay News) -- It has been an elusive goal so far -- finding a potent treatment that can beat back the new coronavirus before it grabs a hold of a patient's immun...
U.S. Administers 300.3 Million Doses of COVID-19 Vaccines - CDC
The United States has administered 300,268,730 doses of COVID-19 vaccines in the country and distributed 371,520,975 doses as of Saturday morning, the U.
U.S. FDA approves Biogen Alzheimer's drug, hailed as 'a big day'
U.
Blackstone, Carlyle and Hellman & Friedman to invest in Medline. Partnership to accelerate Medline’s growth and international expansion
Medline Industries, Inc.
Luring bacteria into a trap
Researchers at ETH Zurich and the University of Basel have developed a vaccine that protects animals from Salmonella.
NIH researchers identify potential new antiviral drug for COVID-19
The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19, suggests a study of cell cultures by researchers at the National Institutes of Health.
NIH launches clinical trial of universal influenza vaccine candidate
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus stra...
AstraZeneca’s Lynparza reduces relapse, death in breast cancer patients
AstraZeneca Plc’s (AZN.
Moderna partners with Thermo Fisher to scale up COVID-19 vaccine production
Moderna Inc said on Tuesday it had entered into an agreement with Thermo Fisher Scientific for manufacturing and packaging its COVID-19 vaccine, as the U.
245
246
247
248
249
250
251
252
253
